Post by Roche Diagnostics USA

We’re proud to announce that our cobas® Mass Spec solution’s Ionify® steroid assays have received CLIA “moderate complexity” classification. This achievement expands our mass spectrometry test menu featuring seven total assays, all CLIA-categorized as moderately complex. Read the full announcement:https://lnkd.in/gnaAEEkZ